{
    "pmcid": "8126837",
    "qa_pairs": {
        "How were the nanobodies against SARS-CoV-2 developed in the study?": [
            "Alpacas were immunized with recombinant spike and RBD proteins to generate nanobody phage display libraries.",
            "Mice were immunized with live SARS-CoV-2 virus to generate nanobody phage display libraries.",
            "Humans were immunized with inactivated SARS-CoV-2 virus to generate nanobody phage display libraries.",
            "Rabbits were immunized with synthetic peptides of SARS-CoV-2 to generate nanobody phage display libraries."
        ],
        "What is the origin and structural characteristic of nanobodies that make them suitable for therapeutic applications?": [
            "Nanobodies are derived from camelids and are small, single-domain antibodies (~12-15 kDa) that are highly stable across a wide range of pH and temperatures.",
            "Nanobodies are derived from rodents and are large, multi-domain antibodies (~150 kDa) that are stable only at neutral pH.",
            "Nanobodies are derived from birds and are medium-sized, dual-domain antibodies (~50 kDa) that are stable only at low temperatures.",
            "Nanobodies are derived from reptiles and are small, single-domain antibodies (~10 kDa) that are unstable at high pH."
        ],
        "What potential therapeutic application is suggested for nanobody-based therapies due to their stability and efficacy?": [
            "Nanobody-based therapies could be developed as inhaled treatments for direct delivery to the respiratory tract.",
            "Nanobody-based therapies could be developed as oral treatments for systemic delivery throughout the body.",
            "Nanobody-based therapies could be developed as topical treatments for application on the skin.",
            "Nanobody-based therapies could be developed as intravenous treatments for direct delivery into the bloodstream."
        ],
        "What structural techniques were used to map the epitopes and determine the binding of nanobodies to the RBD?": [
            "X-ray crystallography and cryo-electron microscopy were used to map the epitopes.",
            "Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry were used to map the epitopes.",
            "Fluorescence microscopy and atomic force microscopy were used to map the epitopes.",
            "Electron paramagnetic resonance (EPR) and Raman spectroscopy were used to map the epitopes."
        ],
        "What was the neutralization potency of the nanobody-Fc fusions against the SARS-CoV-2 variants?": [
            "The nanobody-Fc fusions demonstrated potent neutralizing activity with effective concentrations as low as 0.1 nM.",
            "The nanobody-Fc fusions demonstrated moderate neutralizing activity with effective concentrations as low as 10 nM.",
            "The nanobody-Fc fusions demonstrated weak neutralizing activity with effective concentrations as low as 100 nM.",
            "The nanobody-Fc fusions demonstrated no neutralizing activity with effective concentrations above 1 \u00b5M."
        ]
    }
}